Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objective Recent studies have provided variable information on the frequency and context of diversion and the use of nonprescribed and prescribed stimulant medications in adolescent and young adult populations. The purpose of this systematic review of the literature is to evaluate the extent and characteristics of stimulant misuse and diversion in attention-deficit/hyperactivity disorder (ADHD) and non-ADHD individuals. Method We conducted a systematic review of the literature of available studies looking at misuse and diversion of prescription ADHD medications using misuse, diversion, stimulants, illicit use, and ADHD medications as key words for the search. Results We identified 21 studies representing 113,104 subjects. The studies reported rates of past year nonprescribed stimulant use to range from 5% to 9% in grade school- and high school-age children and 5% to 35% in college-age individuals. Lifetime rates of diversion ranged from 16% to 29% of students with stimulant prescriptions asked to give, sell, or trade their medications. Recent work suggests that whites, members of fraternities and sororities, individuals with lower grade point averages, use of immediate-release compared to extended-release preparations, and individuals who report ADHD symptoms are at highest risk for misusing and diverting stimulants. Reported reasons for use, misuse, and diversion of stimulants include to concentrate, improve alertness, "get high," or to experiment. Conclusions The literature…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and there have been reports of abuse and misuse of stimulant ADHD medication (Kollins, MacDonald, & Rush, 2001; Wilens et al., 2008).”
From Stimulant ADHD medication and risk for substance abuse (2014) · cites this paper as Wilens et al., 2008
In the citing paper
“substantial data indicate that a minority of patients with ADHD divert their stimulant medication for misuse byothers 176 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [176]
In the citing paper
“Given the burden of attention, behavioural and cognitive deficits often noted in children with ADHD and concerns about over prescription of medications with side effects [116], exercise could hold promise as an adjunctive treatment and requires testing in robust well-powered RCTs.”
From Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes (2020) · cites this paper as [116]
In the citing paper
“Long-acting preparations improve compliance and may decrease the potential for abuse, misuse, or recreational use.”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
In the citing paper
“the long-acting formulations are associated with a lower abuse potential compared with the shorter acting formulations”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citation(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
The Worldwide prevalence of ADHD: is it an American condition?
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1,516
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,317
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Cited by
Items 201–300 of 823
Academic doping or Viagra for the brain?
Lucke, J. C., Bell, S., Partridge, B., & Hall, W. (2011) · EMBO Reports · doi:10.1038/embor.2011.15 · Cited by 41
“Empirical surveys about the misuse of prescription stimulants are often cited as evidence that neuro enhancement has become common (Wilens et al, 2008).”
Peña, I. D., & Cheong, J. H. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0037-2 · Cited by 36
“However, there are also indications that individuals with ADHD also misuse their stimulant medications at higher severity than individuals without the disorder (Wilens et al. 2008).”
BackgroundCognitive enhancement in children and adolescents: Is it in their best interests?
Gaucher, N. O., Payot, A., & Racine, É. (2013) · Acta Paediatrica · doi:10.1111/apa.12409 · Cited by 35
“Even young high school and college students report using these substances to facilitate or improve academic work (4,5).”
BackgroundInfluentialJardin, B. F., Looby, A. R., & Earleywine, M. (2011) · Journal of American College Health · doi:10.1080/07448481.2010.513073 · Cited by 46
Molina, B. S. G., Kipp, H., Joseph, H. M., Engster, S. A., Harty, S. C., Dawkins, M., Lindstrom, R. A., Bauer, D. J., & Bangalore, S. S. (2019) · Academic Pediatrics · doi:10.1016/j.acap.2019.06.002 · Cited by 38
Effects of methylphenidate on basic and higher-order oculomotor functions
Allman, A.-A., Ettinger, U., Joober, R., & O’Driscoll, G. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112446531 · Cited by 36
Methylphenidate off-label use and safety
Trenque, T. C., Herlem, E., Taam, M. A., & Dramé, M. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-286 · Cited by 40
“Our data are in line with the few studies of methylphenidate prescription reported to date (Frauger et al. 2011; Knellwolf et al. 2008; Wilens et al. 2008).”
ResultCognitive Enhancement – A Critical Look at the Recent Debate
Hildt, E. (2013) · Trends in augmentation of human performance · doi:10.1007/978-94-007-6253-4_1 · Cited by 41
Forlini, C., & Racine, É. (2012) · AJOB Primary Research · doi:10.1080/21507716.2011.645116 · Cited by 34
“Estimates of the proportion of university students using stimulants to enhance academic performance range from 1.3% to 11% (Franke et al. 2011; Racine and Forlini 2010; Wilens et al. 2008).”
BackgroundInfluentialBrain doping: stimulants use and misuse among a sample of Italian college students
Majori, S., Pilati, S., Gazzani, D., Paiano, J., Ferrari, S., Sannino, A., & Checchin, E. (2017) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2017.58.2.630 · Cited by 50
“The prevalence of NMUPS (Methylphenidate and Amphetamines) has been found to range from 5% to 35% in surveys among young adult and adolescent populations of North America [18] and 25.”
BackgroundResultInfluentialTreatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review
Zaso, M. J., Park, A., & Antshel, K. M. (2020) · Journal of Attention Disorders · doi:10.1177/1087054715569280 · Cited by 31
Cognitive Behavioral Treatment Outcomes in Adolescent ADHD
Antshel, K. M., Faraone, S. V., & Gordon, M. (2012) · Focus · doi:10.1176/appi.focus.10.3.334 · Cited by 27
Ethical Challenges in Digital Psychology and Cyberpsychology
Parsons, T. D. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108553384 · Cited by 39
Gonon, F., Guilé, J.-M., & Cohen, D. (2010) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2010.02.004 · Cited by 70
Skoglund, C. B., Brandt, L., Almqvist, C., D'Onofrio, B. M., Konstenius, M., Franck, J., & Larsson, H. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000501 · Cited by 41
“Also, central stimulant medications are controlled substances that increase dopamine in parts of the brain involved in the development of addictive behaviors,(8) and MPH can be recreationally used and abused.(9) Just recently, however, 2 randomized controlled trials(10,11) showed that individuals with ADHD and SUD exp…”
BackgroundHildt, E., Lieb, K., Bagusat, C., & Franke, A. G. (2015) · BioMed Research International · doi:10.1155/2015/621075 · Cited by 32
Bjarnadottir, G., Haraldsson, H. M., Rafnar, B. O., Sigurðsson, E., Steingrímsson, S., Jóhannsson, M., Bragadottir, H., & Magnússon, A. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000115 · Cited by 38
“In a systemic review, Wilens and colleagues showed that the base rate of MPH abuse was about 5% to 35% in college-aged individuals (Wilens et al., 2008).”
BackgroundVargo, E. J., James, R. A., Agyeman, K. D., MacPhee, T., McIntyre, R., Ronca, F., & Petróczi, A. (2014) · Performance Enhancement & Health · doi:10.1016/j.peh.2015.02.001 · Cited by 36
Muld, B. B., Jokinen, J., Bölte, S., & Hirvikoski, T. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.11.005 · Cited by 39
“However, individuals who exhibit a high symptom severity of both ADHD and SUD, in addition to comorbid psychiatric symptoms, are often found in other compulsory care settings, such as forensic care and institutional youth care, and in voluntary outpatient and inpatient addiction and psychiatric clinics (Klein et al.,…”
BackgroundBoclin, K. D. L. S., Cicilio, F. F. C., Faé, G., Fanti, G., Centenaro, G., Pellizzari, T., Gaviolli, E., Mário, D. N., & Rigo, L. (2020) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2019.0182.r1.21102019 · Cited by 47
Carnovale, C., Mazhar, F., Pozzi, M., Gentili, M., Clementi, E., & Radice, S. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1550069 · Cited by 36
Correlation Between Methylphenidate and Ritalinic Acid Concentrations in Oral Fluid and Plasma
Marchei, E., Farré, M., Lozano, R. P., García‐Algar, Ó., Pellegrini, M., Pacifici, R., & Pichini, S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.138396 · Cited by 31
Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
Marchei, E., Farré, M., Pellegrini, M., García‐Algar, Ó., Vall, O., Pacifici, R., & Pichini, S. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2009.12.038 · Cited by 30
“Specifically, these two matrices can be used to monitor recent use and misuse of MPH in children, adolescents and young adults [13–15].”
Ginsberg, Y., Långström, N., Larsson, H., & Lichtenstein, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.22 · Cited by 38
Houghton, S. J., Alsalmi, N., Tan, C. S. C., Taylor, M. F., & Durkin, K. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712473182 · Cited by 35
Gray, W. N., Kavookjian, J., Shapiro, S. K., Wagoner, S. T., Schaefer, M. R., Rawlinson, A. R., & Hinnant, J. B. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000511 · Cited by 32
Promising Medications for Cocaine Dependence Treatment
Somaini, L., Donnini, C., Raggi, M. A., Amore, M., Ciccocioppo, R., Saracino, M. A., Kallupi, M., Malagoli, M., Gerra, M. L., & Gerra, G. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911795933893 · Cited by 32
“In contrast, in ADHD patients with comorbid alcohol abuse, treatment with atomoxetine leads to a reduction of cumulative heavy drinking days as well as improving ADHD symptoms [131].”
BackgroundKast, K. A., Rao, V., & Wilens, T. E. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20m13598 · Cited by 35
Self-citationManaging the Risks of ADHD Treatments
Schneider, B. N., & Enenbach, M. J. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0479-3 · Cited by 33
Parsons, T. D. (2018) · Educational communications and technology: issues and innovations · doi:10.1007/978-3-030-02631-8_11 · Cited by 30
Faison, S. L., Fry, N., Adewole, T., Odebo, O., Wang, Z., Maletic, V., & Nasser, A. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001361 · Cited by 28
“However, stimulants may be contraindicated in patients with other conditions (eg, insomnia, anorexia, bipolar disorders, cardiovascular abnormalities such as hypertension or arrythmias), have a generally short (eg, 3–12 hours) duration of action,(17) and the potential for abuse and diversion.(18,19) Most frequently, c…”
BackgroundButler, S. F., Faraone, S. V., Rostain, A. L., Newcorn, J. H., Antshel, K. M., Robbins, R. S., & Green, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667118 · Cited by 39
“The motivation most often reported for NMU by oral routes and snorting was performance enhancement, as others have noted (3, 7, 10, 40).”
BackgroundQuintero, G. (2012) · Contemporary Drug Problems · doi:10.1177/009145091203900307 · Cited by 28
Prevalence of ADHD in Publicly Insured Adults
Zhu, Y., Liu, W. Y., Li, Y., Wang, X., & Winterstein, A. G. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717698815 · Cited by 36
“Given that previous studies reported prevalent nonmedical use and misuse of prescription stimulants among young adults (Kaye & Darke, 2012; McCabe, Knight, Teter, & Wechsler, 2005; Wilens et al., 2008), future research should address what alternative indications or purposes for ADHD medication use exist in this popula…”
Maneeton, B., Maneeton, N., Intaprasert, S., & Wootiluk, P. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62714 · Cited by 27
“33,34 Therefore, alternative pharmacological treatment in those patients is necessary.”
Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities
Vagwala, M. K., Bicquelet, A., Didžiokaitė, G., Coomber, R., Corrigan, O., & Singh, I. (2017) · Neuroethics · doi:10.1007/s12152-017-9336-5 · Cited by 31
“Around the world, quantitative reports of PCE prevalence among university students demonstrate that PCE use is the exception, not the norm [11, 33, 35, 45, 46].”
Roman, B. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00003 · Cited by 36
“Since psycho-stimulants convey the most robust effect size, and since long-acting (compared with immediate-acting) stimulants possess reduced potential for misuse or diversion,[64] the first line medication treatment for ADHD is a long-acting psycho-stimulant.”
BackgroundWaes, V. V., Ehrlich, S., Beverley, J. A., & Steiner, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.024 · Cited by 26
“In addition, methylphenidate is increasingly used as a recreational drug or as a so-called cognitive enhancer (Greely et al., 2008) to improve concentration and performance in certain tasks or to study harder (Kollins, 2008; Swanson and Volkow, 2008; Wilens et al., 2008).”
BackgroundADHD with comorbid substance use disorder: review of treatment
Magon, R., & Müller, U. (2012) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.111.009340 · Cited by 31
“A systematic review (Wilens 2008b) found that 5–9% of school students and 5–35% of college students in the USA had used a non-prescribed stimulant over the previous 12 months.”
BackgroundFaraone, S. V., Hess, J., & Wilens, T. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719843182 · Cited by 27
Self-citationCesar, E. L. D. R., Wagner, G. A., Castaldelli-Maia, J. M., Silveira, C. M., de Andrade, A. G., & de Oliveira, L. G. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012000600001 · Cited by 47
Karpouzis, F., Bonello, R., & Pollard, H. P. (2010) · Chiropractic & Manual Therapies · doi:10.1186/1746-1340-18-13 · Cited by 29
“Even though psychostimulants are the first line of therapy for paediatric AD/HD [2,12,22,23], the evidence reveals that up to 30% of these children do not show clinically significant outcomes, and others experience sideeffects [12,24-28], and need to discontinue their medications [5,28].”
BackgroundAttention Deficit Hyperactivity Disorder and Substance Use Disorders
Szobot, C. M., & Bukstein, O. G. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.003 · Cited by 35
Feldman, M., Bélanger, S. A., & Canadian Paediatric Society (2009) · Paediatrics & Child Health · doi:10.1093/pch/14.9.593 · Cited by 28
Substance Use Patterns Among Adolescents: A Latent Class Analysis
Lee, H., Yang, K., Palmer, J. E., Kameg, B., Clark, L., & Greene, B. W. (2019) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390319858658 · Cited by 27
“Moreover, performance enhancement and recreational misuse account for nonmedical prescription medication use (McCabe, West, & Boyd, 2013; Wilens et al., 2008).”
BackgroundNational Trends in Psychostimulant-Related Deaths: 1999–2009
Calcaterra, S. L., & Binswanger, I. A. (2013) · Substance Abuse · doi:10.1080/08897077.2012.726959 · Cited by 28
Manor, I., Ben‐Hayun, R., Aharon‐Peretz, J., Salomy, D., Weizman, A., Daniely, Y., Megiddo, D., Newcorn, J. H., Biederman, J., & Adler, L. A. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07767 · Cited by 30
Self-citationPsychiatric Comorbidity and Complications
Mason, M. J., Aplasca, A., Morales-Theodore, R., Zaharakis, N. M., & Linker, J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.02.007 · Cited by 27
Martin, C. D., Fricke, D., Vijayashanthar, A., Lowinger, C., Koutsomitis, D., Popoola, D. O., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.001 · Cited by 28
“These findings are important, given the substantial number of healthy adolescents taking MP illicitly (Olfson et al., 2002; Wilens et al., 2008) but subsequently after discontinuing treatment (Cox et al.”
Acute Effects of Whole Body Vibration on Inhibition in Healthy Children
den Heijer, A. E., Groen, Y., Fuermaier, A. B. M., van Heuvelen, M. J. G., van der Zee, E. A., Tucha, L., & Tucha, O. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140665 · Cited by 31
Attention Deficit Hyperactivity Disorder Medication Use Among Teens and Young Adults
Johansen, M. E., Matic, K., & McAlearney, A. S. (2015) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2015.04.009 · Cited by 28
“Clinicians may be biased to not prescribe medications due to subconscious biases [33,34] or may associate blacks with greater risk of ADHD medication diversion although previous literature has refuted this association [35].”
ResultLife-long consequences of juvenile exposure to psychotropic drugs on brain and behavior
Steiner, H., Warren, B. L., Waes, V. V., & Bolaños‐Guzmán, C. A. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00002-7 · Cited by 24
“According to surveys, up to 10-20% or more of college students use MPH to improve concentration, stay awake to study, or party (White et al., 2006; Kollins, 2008; Wilens et al., 2008).”
BackgroundCepeda, M. S., Fife, D., Berwaerts, J., Friedman, A., Yuan, Y., & Mastrogiovanni, G. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.945591 · Cited by 24
“The effect of gender on the risk of misuse or abuse of ADHD medications is not clear (12).”
BackgroundRoberts, D. K., Alderson, R. M., Betancourt, J. L., & Bullard, C. C. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102039 · Cited by 28
Open Label Pilot Study of Atomoxetine in Adults With ADHD and Substance Use Disorder
Adler, L. A., Guida, F. V., Irons, S., & Shaw, D. M. (2010) · Journal of Dual Diagnosis · doi:10.1080/15504263.2010.537224 · Cited by 27
Self-citationWade, L., Forlini, C., & Racine, É. (2014) · BMC Medical Ethics · doi:10.1186/1472-6939-15-37 · Cited by 25
“Finally, in contrast to the non-medical use of stimulants for CE [25,26], no strong prevalence data exists that bolsters claims of a CE effect by providing evidence of a perceived CE effect by users.”
BackgroundLloyd, S. A., Oltean, C., Pass, H. I., Phillips, B., Staton, K., Robertson, C. L., & Shanks, R. A. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.038 · Cited by 28
Ambivalent attitudes about teaching children with attention deficit/hyperactivity disorder (ADHD)
Anderson, D., Watt, S., & Shanley, D. C. (2017) · Emotional and Behavioural Difficulties · doi:10.1080/13632752.2017.1298242 · Cited by 39
“…although the scientific literature has shown medication to be one of the most effective treatments for ADHD (e.g. MTA Cooperative Group 1999), there are also widespread social concerns about overprescription, side effects and misuse of medications used to treat ADHD (Haug 2014; Wilens et al. 2008).”
BackgroundCognitive Enhancement and Coping in an Australian University Student Sample
Riddell, C., Jensen, C., & Carter, O. L. (2017) · Journal of Cognitive Enhancement · doi:10.1007/s41465-017-0046-z · Cited by 28
“For example, in a systematic review, past-year prescription stimulant use for the purposes of study-related CE by college students in the United States was reported to range between 5% and 35% (Wilens et al., 2008).”
BackgroundResultInfluentialModelling predictors of UK undergraduates’ attitudes towards smart drugs
Champagne, J., Gardner, B., & Dommett, E. J. (2019) · Trends in Neuroscience and Education · doi:10.1016/j.tine.2019.02.001 · Cited by 31
“These drugs were all chosen based on frequent citation in the literature on smart drug use [45-47] and recent work showing similar use of the”
BackgroundWhiteside, L., Cunningham, R. M., Bonar, E. E., Blow, F. C., Ehrlich, P. F., & Walton, M. A. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.05.003 · Cited by 25
“The prevalence of NPSU in college students is higher with rates varying between 5 and 35% (Arria et al., 2008; DeSantis, Webb, & Noar, 2008; McCabe, Teter, & Boyd, 2006; Sweeney, Sembower, Ertischek, Shiffman, & Schnoll, 2013; Wilens et al., 2008).”
Patrick, K. S., Corbin, T. R., & Murphy, C. E. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24202 · Cited by 25
“The present review chronicles the pharmaceutical literature pertaining to EPH: (1) as a selective dopaminergic agonist; (2) as a candidate agent for personalized ADHD pharmacotherapy in the emerging field of genome-based diagnostics; (3) as a biomarker of concomitant MPH-ethanol exposure; (4) as pertinent to the mecha…”
BackgroundBaraskewich, J., & McMorris, C. A. (2019) · Current Developmental Disorders Reports · doi:10.1007/s40474-019-0154-9 · Cited by 25
Brain Processes in Discounting: Consequences of Adolescent Methylphenidate Exposure
Adriani, W., Zoratto, F., & Laviola, G. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_156 · Cited by 25
“So far, there have been few systematic studies on the sequelae of such widespread MPH misuse in human adolescents; few published investigations have assessed why MPH is so widely consumed, for recreational purpose and not just as a therapy for ADHD (Arria and Wish 2006; Wilens et al. 2008; Bogle and Smith 2009), and w…”
BackgroundFaison, S. L., Fry, N., Adewole, T., Odebo, O., Schwabe, S., Wang, Z., Maletic, V., & Nasser, A. F. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00992-6 · Cited by 24
Dietz, P., Iberl, B., Schütt, E., van Poppel, M. N. M., Ulrich, R., & Sattler, M. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00494 · Cited by 29
Virtual Environments for Substance Abuse Assessment and Treatment
Bordnick, P. S., & Washburn, M. (2019) · Virtual reality technologies for health and clinical applications · doi:10.1007/978-1-4939-9482-3_6 · Cited by 27
Ghanizadeh, A. J. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.972975 · Cited by 23
Deception for Drugs: Self-Reported “Doctor Shopping” Among Young Adults
Stogner, J., Sanders, A. N., & Miller, B. (2014) · Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2014.05.140107 · Cited by 22
“Patients may retain a portion of a needed prescription to sell, give away, or use themselves for recreational purposes.(6,7) Theft from the supply chain or patients,(4) fraudulently altered prescriptions,(8) stolen prescription pads,(9) international travelers,(4) and “rogue on-line pharmacies”(10) all likely partiall…”
BackgroundChiappini, S., Gramuglia, P. D., Mosca, A., Cavallotto, C., Miuli, A., Corkery, J., Guirguis, A., Schifano, F., & Martinotti, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1508732 · Cited by 30
Forrest, J., Chen, W. T., & Jagadheesan, K. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1612785 · Cited by 25
Mommaerts, J.-L., Beerens, G., den Block, L. V., Soetens, E. L. L., Schol, S., Vijver, E. V. D., & Devroey, D. (2013) · Psychology Research and Behavior Management · doi:10.2147/prbm.s47526 · Cited by 25
Brown, R. W., Hughes, B. A., Hughes, A. B., Sheppard, A. B., Perna, M. K., Ragsdale, W., Roeding, R. L., & Pond, B. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112454227 · Cited by 28
Peña, I. D., Yoon, S. Y., Lee, J. C., de la Peña, J. B., Sohn, A. R., Ryu, J. H., Shin, C. Y., & Cheong, J. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2564-1 · Cited by 25
Safety of stimulant treatment in attention deficit hyperactivity disorder: part II
Merkel, R. L. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2010.503238 · Cited by 23
Muld, B. B., Jokinen, J., Bölte, S., & Hirvikoski, T. (2016) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0195-4 · Cited by 25
ADHD, Socioeconomic Status, Medication Use, and Academic Ethic
Simoni, Z. R., & Drentea, P. (2016) · Sociological Focus · doi:10.1080/00380237.2016.1107713 · Cited by 24
“As noted by Wilens et al. (2008) children and adolescents may divert, sell, or abuse ADHD medication, thus manipulating the possible benefits or harms of medication consequences (many girls use these medications for weight control) (DeSantis, Webb, and Noar 2008).”
BackgroundDiversion of ADHD Stimulants and Victimization Among Adolescents
Epstein-Ngo, Q. M., McCabe, S. E., Veliz, P. T., Stoddard, S. A., Austic, E. A., & Boyd, C. J. (2015) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsv105 · Cited by 23
“Given the increasing and ongoing prescription of stimulant medication for ADHD treatment (Pliszka, 2007; Visser et al., 2014; Wilens et al., 2008) and the fact that these medications are being nonmedically used to improve school performance or enhance highs from other drugs (Kroutil et al., 2006),…”
BackgroundResultInfluentialStimulant Treatment of ADHD and Risk of Sudden Death in Children
Vitiello, B., & Towbin, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050619 · Cited by 23
Zhu, H., Patrick, K. S., Straughn, A. B., Reeves, O. T., Bernstein, H., Shi, J., Johnson, H. J., Knight, J. M., Smith, A. T., Malcolm, R. J., et al. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000721 · Cited by 24
Becke, M., Tucha, L., Weisbrod, M., Aschenbrenner, S., Tucha, O. M., & Fuermaier, A. B. M. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02318-y · Cited by 22
Blanch, B., Buckley, N. A., Mellish, L., Dawson, A. H., Haber, P., & Pearson, S. (2015) · Drug Safety · doi:10.1007/s40264-015-0294-8 · Cited by 21
Safety of stimulant treatment in attention deficit hyperactivity disorder: part I
Merkel, R. L., & Kuchibhatla, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903279956 · Cited by 24
“Therefore, the non-medical use of stimulants among young people appears to vary from 5 to 35%, depending on methodology [77].”
BackgroundCarias, E., Fricke, D., Vijayashanthar, A., Smith, L. C., Somanesan, R., Martin, C. D., Kalinowski, L., Popoola, D. O., Hadjiargyrou, M., Komatsu, D. E., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.08.014 · Cited by 21
“For instance, healthy students may only administer MP to enhance arousal and cognitive ability in order to increase academic performance during the week and only when school is in session [3,5,16,17].”
ADHD Medication Trends in Turkey: 2009-2013
Öner, Ö., Yılmaz, E. Ş., Karadağ, H., Vural, M., Vural, E. H., Akbulat, A., Gürsöz, H., Türkçapar, M. H., & Kerman, S. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714523129 · Cited by 27
“Overdiagnosis, prescription of unnecessary drugs, misuse, and diversion are obvious problems with possible serious consequences (Weyandt et al., 2013; Wilens et al., 2008).”
BackgroundThe Prescription Drug Abuse Epidemic
Yu, H.-Y. E. (2012) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2012.06.006 · Cited by 22
Chen, L., Strain, E. C., Crum, R. M., Storr, C. L., & Mojtabai, R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.09.781 · Cited by 22
What Exactly Are the Benefits of Stimulants for ADHD?
Advokat, C. D. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708329781 · Cited by 24
“This is especially true of undergraduate populations, and the use of stimulants for the treatment of ADHD in college students has increased dramatically in the past few years (for a review, see Wilens et al., 2008).”
BackgroundInfluentialSchouw, M. L. J., de Ruiter, M. B., Kaag, A. M., van den Brink, W., Lindauer, R., & Reneman, L. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.010 · Cited by 22
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Bukstein, O. G. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_148 · Cited by 23
Papazisis, G., Tsakiridis, I. G., Pourzitaki, C., Apostolidou, E., Spachos, D., & Kouvelas, D. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1325373 · Cited by 30
“The prevalence of nonmedical use of prescription stimulants is also considerably high among college students with past-year use rates ranging from 5% to 35% reported in various studies © Taylor & Francis Group, LLC among college-age individuals (Wilens et al., 2008).”
BackgroundLeBlanc-Duchin, D., & Taukulis, H. K. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.12.004 · Cited by 24
Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement
Brand, R., Wolff, W., & Ziegler, M. D. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01226 · Cited by 21
Parks, K. A., Levonyan‐Radloff, K., Przybyla, S., Darrow, S. L., Muraven, M., & Hequembourg, A. L. (2017) · Journal of American College Health · doi:10.1080/07448481.2017.1341895 · Cited by 27
“In addition, a growing number of university students indicate sharing and selling their PD to fellow students.(14,29) These findings all suggest that NMUPD and availability on university campuses are a growing public health problem.”
BackgroundResultInfluentialMicoulaud, F. G. (2015) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000213 · Cited by 29
“Prescription stimulants such as methylphenidate (MPH) and amphetamines are supposed to be the most frequently consumed smart drugs, especially in college campuses where, depending on the survey, 5 to 35% of healthy students reported having consumed them for neuroenhancement purposes in the past year (for a meta-analys…”
BackgroundOveruse of methylphenidate: an analysis of Swedish pharmacy dispensing data
Bjerkeli, P. J., Perez Vicente, R., Mulinari, S., Johnell, K., & Merlo, J. (2018) · Clinical Epidemiology · doi:10.2147/clep.s178638 · Cited by 18
Prescription medication exchange patterns among methadone maintenance patients
Caviness, C. M., Anderson, B. J., de Dios, M. A., Kurth, M. E., & Stein, M. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.007 · Cited by 17
“…(giving or selling medication to someone) or receiving (borrowing or buying from someone) also contributes to the illegal use of prescription medications (Ellis and Mullan, 2009; Ellis et al., 2011; Goldsworthy et al., 2008; McCabe et al., 2007, 2011; Petersen et al., 2008; Wilens et al., 2008).”
BackgroundCastrillón, J. J. C., García, S., Luna, J. G., Morán, M., Ocampo, D., & Ortiz, L. (2017) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v65n1.56471 · Cited by 18
Ramachandran, S., Dertien, D., & Bentley, S. (2020) · Journal of Addictive Diseases · doi:10.1080/10550887.2020.1732762 · Cited by 21
“1836 Paid at least in part by insurance 71 (90) 24 (83) 47 (94) Paid in cash despite having insurance 4 (5) 3 (10) 1 (2) Uninsured; Paid in cash 4 (5) 2 (7) 2 (4)”
Nguyen, N. T., Rakow, T., Gardner, B., & Dommett, E. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244865 · Cited by 16
Metadata
- Authors
- WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S.
- Affiliations
- Harvard University (US)
- Corresponding author
- WILENS, TIMOTHY E.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 47
- Issue
- 1
- Pages
- 21-31
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1970031540
- Cited by
- 824
- References
- 56
- Citations by year
- 2026: 16 · 2025: 44 · 2024: 21 · 2023: 17 · 2022: 26 · 2021: 87 · 2020: 43 · 2019: 50 · 2018: 36 · 2017: 49 · 2016: 60 · 2015: 52 · 2014: 73 · 2013: 49 · 2012: 70
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- the National Institute of Drug Abuse (U10 DA15831 and U10 DA13046)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant abuse, prescription drug diversion, ADHD medication, adolescents, young adults, university students, risk factors
- MeSH terms
- Adolescent, Adult, Amphetamines, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Methylphenidate, Drug Prescriptions, Self Administration, Illicit Drugs, United States, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.